FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4313401000001108: Anzemet 20mg/mL injection solution 0.625mL vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    13034501000001116 Anzemet 20mg/mL injection solution 0.625mL vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    13182601000001111 Anzemet 20mg/mL injection solution 0.625mL vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    13182701000001118 Anzemet 12.5mg/0.625mL injection solution vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Anzemet 20mg/mL injection solution 0.625mL vial Is a Dolasetron mesilate 20mg/mL injection solution 0.625mL vial false Inferred relationship Existential restriction modifier
    Anzemet 20mg/mL injection solution 0.625mL vial Legal category Prescription Only Medicine false Additional relationship Existential restriction modifier
    Anzemet 20mg/mL injection solution 0.625mL vial Availability Product is currently available false Additional relationship Existential restriction modifier
    Anzemet 20mg/mL injection solution 0.625mL vial CSM recommendation to report adverse reactions Report all adverse reactions to the CSM false Additional relationship Existential restriction modifier
    Anzemet 20mg/mL injection solution 0.625mL vial Product name type Brand name false Additional relationship Existential restriction modifier
    Anzemet 20mg/mL injection solution 0.625mL vial NHS prescribing status NHS prescribable false Additional relationship Existential restriction modifier
    Anzemet 20mg/mL injection solution 0.625mL vial Has active ingredient Substance with 5-hydroxytryptamine-3-receptor antagonist mechanism of action false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start